Baxter's $4B buyout of Gambro gets OK from Australian regulators

09/6/2013 | MassDevice.com (Boston)

Baxter's acquisition of Gambro, a Swedish maker of dialysis systems, for almost $4 billion has won approval from business regulators in Australia. The decision is contingent on Baxter divesting itself of its renal replacement therapy unit. The acquisition also has the green light from regulators in the U.S., Europe, Canada, Turkey, Ukraine, Brazil, South Korea and China.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director Quality Improvement
Molina Healthcare of Texas
San Antonio, TX
Senior Medical Director
Network Health
Medford, MA
SVP/Head of Health Plans and Managed Care
Avalere Health
Washington, DC
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR